Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging

被引:79
作者
Hectors, Stefanie J. [1 ,2 ]
Wagner, Mathilde [1 ,2 ,3 ]
Bane, Octavia [1 ,2 ]
Besa, Cecilia [1 ,2 ]
Lewis, Sara [1 ,2 ]
Remark, Romain [4 ]
Chen, Nelson [1 ,2 ]
Fiel, M. Isabel [5 ]
Zhu, Hongfa [5 ]
Gnjatic, Sacha [6 ]
Merad, Miriam [4 ]
Hoshida, Yujin [7 ]
Taouli, Bachir [1 ,2 ]
机构
[1] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA
[3] UPMC, Sorbonne Univ, Hop Pitie Salpetriere, AP HP,Dept Radiol, Paris, France
[4] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Oncol Sci, New York, NY 10029 USA
[7] Icahn Sch Med Mt Sinai, Dept Med, Div Liver Dis, New York, NY 10029 USA
关键词
GENE-EXPRESSION PROGRAMS; DCE-MRI; PERFUSION QUANTIFICATION; TUMOR HETEROGENEITY; LIVER; CANCER; CELLS; IMMUNOTHERAPY; TREMELIMUMAB; PARAMETERS;
D O I
10.1038/s41598-017-02706-z
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tumour heterogeneity poses a significant challenge for treatment stratification. The goals of this study were to quantify heterogeneity in hepatocellular carcinoma (HCC) using multiparametric magnetic resonance imaging (mpMRI), and to report preliminary data correlating quantitative MRI parameters with advanced histopathology and gene expression in a patient subset. Thirty-two HCC patients with 39 HCC lesions underwent mpMRI including diffusion-weighted imaging (DWI), blood-oxygenation-level-dependent (BOLD), tissue-oxygenation-level-dependent (TOLD) and dynamic contrast-enhanced (DCE)-MRI. Histogram characteristics [central tendency (mean, median) and heterogeneity (standard deviation, kurtosis, skewness) MRI parameters] in HCC and liver parenchyma were compared using Wilcoxon signed-rank tests. Histogram data was correlated between MRI methods in all patients and with histopathology and gene expression in 14 patients. HCCs exhibited significantly higher intra-tissue heterogeneity vs. liver with all MRI methods (P < 0.030). Although central tendency parameters showed significant correlations between MRI methods and with each of histopathology and gene expression, heterogeneity parameters exhibited additional complementary correlations between BOLD and DCE-MRI and with histopathologic hypoxia marker HIF1 alpha and gene expression of Wnt target GLUL, pharmacological target FGFR4, stemness markers EPCAM and KRT19 and immune checkpoint PDCD1. Histogram analysis combining central tendency and heterogeneity mpMRI features is promising for non-invasive HCC characterization on the imaging, histologic and genomics levels.
引用
收藏
页数:12
相关论文
共 58 条
[41]   Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients [J].
Mayerhoefer, Marius E. ;
Karanikas, Georgios ;
Kletter, Kurt ;
Prosch, Helmut ;
Kiesewetter, Barbara ;
Skrabs, Cathrin ;
Porpaczy, Edit ;
Weber, Michael ;
Knogler, Thomas ;
Sillaber, Christian ;
Jaeger, Ulrich ;
Simonitsch-Klupp, Ingrid ;
Ubl, Philipp ;
Muellauer, Leonhard ;
Dolak, Werner ;
Lukas, Julius ;
Raderer, Markus .
CLINICAL CANCER RESEARCH, 2015, 21 (11) :2506-2513
[42]   Hepatocellular Carcinoma: Illustrated Guide to Systematic Radiologic Diagnosis and Staging According to Guidelines of the American Association for the Study of Liver Diseases [J].
McEvoy, Sinead H. ;
McCarthy, Colin J. ;
Lavelle, Lisa P. ;
Moran, Deirdre E. ;
Cantwell, Colin P. ;
Skehan, Stephen J. ;
Gibney, Robert G. ;
Malone, Dermot E. .
RADIOGRAPHICS, 2013, 33 (06) :1653-1668
[43]   The blockade of immune checkpoints in cancer immunotherapy [J].
Pardoll, Drew M. .
NATURE REVIEWS CANCER, 2012, 12 (04) :252-264
[44]   Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Giadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla [J].
Pintaske, J ;
Martirosian, P ;
Graf, H ;
Erb, G ;
Lodemann, KP ;
Claussen, CD ;
Schick, F .
INVESTIGATIVE RADIOLOGY, 2006, 41 (03) :213-221
[45]   Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma [J].
Qin, Lei ;
Li, Xiang ;
Stroiney, Amanda ;
Qu, Jinrong ;
Helgager, Jeffrey ;
Reardon, David A. ;
Young, Geoffrey S. .
NEURORADIOLOGY, 2017, 59 (02) :135-145
[46]   In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide [J].
Remark, Romain ;
Merghoub, Taha ;
Grabe, Niels ;
Litjens, Geert ;
Damotte, Diane ;
Wolchok, Jedd D. ;
Merad, Miriam ;
Gnjatic, Sacha .
SCIENCE IMMUNOLOGY, 2016, 1 (01)
[47]   Radiogenomics: Creating a link between molecular diagnostics and diagnostic imaging [J].
Rutman, Aaron M. ;
Kuo, Michael D. .
EUROPEAN JOURNAL OF RADIOLOGY, 2009, 70 (02) :232-241
[48]   A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C [J].
Sangro, Bruno ;
Gomez-Martin, Carlos ;
de la Mata, Manuel ;
Inarrairaegui, Mercedes ;
Garralda, Elena ;
Barrera, Pilar ;
Ignacio Riezu-Boj, Jose ;
Larrea, Esther ;
Alfaro, Carlos ;
Sarobe, Pablo ;
Jose Lasarte, Juan ;
Perez-Gracia, Jose L. ;
Melero, Ignacio ;
Prieto, Jesus .
JOURNAL OF HEPATOLOGY, 2013, 59 (01) :81-88
[49]   Decoding global gene expression programs in liver cancer by noninvasive imaging [J].
Segal, Eran ;
Sirlin, Claude B. ;
Ooi, Clara ;
Adler, Adam S. ;
Gollub, Jeremy ;
Chen, Xin ;
Chan, Bryan K. ;
Matcuk, George R. ;
Barry, Christopher T. ;
Chang, Howard Y. ;
Kuo, Michael D. .
NATURE BIOTECHNOLOGY, 2007, 25 (06) :675-680
[50]   The future of immune checkpoint therapy [J].
Sharma, Padmanee ;
Allison, James P. .
SCIENCE, 2015, 348 (6230) :56-61